Medical charts reviews of patients with long-term treatment of risperidone long-acting injectable.
Phase of Trial: Phase IV
Latest Information Update: 07 Jul 2014
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Johnson & Johnson
- 21 Oct 2009 Actual patient number (342) added as reported by ClinicalTrials.gov.
- 14 Apr 2008 New trial record.